All articles by Rebecca Trager – Page 64
-
NewsUS Chemical Safety Board controversy continues
The CSB is facing more tumult, with staff shake-ups and new revelations about its top lawyer
-
NewsEPA under pressure over Enlist Duo herbicide
WHO has designated Enlist Duo’s two ingredients as a probable and possible human carcinogens
-
News
Chemical reform bill advances in US Congress
Bipartisan legislation to finally overhaul the Toxic Substances Control Act has overwhelmingly passed the House and soon heads to the Senate
-
News
NIH plan to get drug development unit back online
The US National Institutes of Health to address deficiencies in unit that makes drugs for research studies
-
News
US may have tested mustard gas on troops by race
Pentagon accused of race-based chemical weapons experiments on US troops during second world war
-
BusinessSafer substitutes show growth potential
The global market for alternative products based on ‘green’ chemistry is growing fast, fuelled by regulation and consumer demand
-
Business
Alnylam accuses Dicerna of stealing trade secrets
Firm claims rights to GalNAc conjugated siRNA technology acquired from Merck & Co
-
News
Political bickering may block key US environmental appointments
Republicans threaten to hold up confirmation of new science head for Environmental Protection Agency
-
NewsSynthetic cannabinoid poisonings surge in US
Poison control centers saw a 229% jump in calls related to synthetic cannabinoid use this year
-
Business
Suspect suicide won’t end trade secret theft probe
An ex-PPG chemist who was arrested for selling trade secrets to a Chinese firm has killed himself, but the Justice Department will continue its investigation
-
NewsChemical sciences literature dominated by five publishing houses
Big five control publishing of more than 50% of global academic papers, rising to over 70% in chemistry
-
News
US spends billions annually on unreproducible preclinical research
Study estimates $28 billion spent yearly on preclinical research that can’t be replicated
-
News
NIH drug manufacturing unit shut down
The US National Institutes of Health suspends operations at its pharmaceutical development section after FDA inspectors uncover serious manufacturing issues
-
BusinessBMS sues executive for joining rival company
Bristol-Myers Squibb’s lawsuit against its former immuno-oncology chief who left to work for AstraZeneca has implications for biopharma industry
-
News
Call to embed science in US foreign policy
National Research Council tells US to take science and technology more seriously on the diplomatic stage
-
NewsBiosafety blunder as US sends live anthrax to labs around world
Key government committee demands answers after Department of Defense inadvertently sends out live pathogen
-
NewsNIH-funded principal investigators fell sharply in 2010
New analysis finds PIs funded by US National Institutes of Health grew steadily from 1985 to around 2010, but has since dropped steeply
-
News
Chemical regulation reform gains momentum in both chambers of US Congress
Bipartisan bill to revamp outdated legislation is advancing in the Senate and the House, but the window to enact reform could be narrow
-
NewsFallout from rogue US drug lab chemist could lead to thousands of retrials
Ruling by Massachusetts court means defendants in drug cases can pursue retrials without fear of harsher sentences
-
NewsUS targets neonicotinoid use in pollinator plan
Obama’s new strategy to promote pollinator health includes re-evaluating neonicotinoid pesticides